CI
ZVRA icon

Cowen Inc’s Zevra Therapeutics ZVRA Stock Holding History

Cowen Inc’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$438K Sell
15,625
-11,782
-43% -$296K 0.03% 205
2019
Q1 		$732K Sell
27,407
-7,988
-23% -$294K 0.08% 137
2018
Q4 		$1.01M Buy
35,395
+12,500
+55% +$506K 0.11% 133
2018
Q3 		$1.76M Hold
22,895
– – 0.16% 108
2018
Q2 		$2.38K Buy
+22,895
New +$2.24M 0.1% 141
2016
Q2 		– Sell
-3,402
Closed -$789K – 303
2016
Q1 		$789K Buy
3,402
+1,304
+62% +$316K 0.03% 161
2015
Q4 		$667K Buy
+2,098
New +$570K 0.05% 174

Other funds holding ZVRA

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cowen Inc's ZVRA Position: Q2 2019 in Review

Cowen Inc reduced its Zevra Therapeutics (ZVRA) stake by 43% in Q2 2019, selling an estimated $296K and leaving 15,625 shares worth $438K. The position accounts for 0.03% of the portfolio, ranked #205.

Cowen Inc first reported a position in ZVRA in Q4 2015 and has held it in 7 quarters since. The position peaked at $1.76M in Q3 2018. 32 funds tracked by Wall St. Rank hold ZVRA as of Q2 2019.

  • Cowen Inc held 15,625 shares of Zevra Therapeutics worth $438K as of Q2 2019.
  • Cowen Inc sold 11,782 Zevra Therapeutics shares in Q2 2019, an estimated $296K.
  • Zevra Therapeutics made up 0.03% of Cowen Inc's portfolio in Q2 2019, its #205 holding.
  • Cowen Inc first reported a position in Zevra Therapeutics in Q4 2015 and has held it in 7 quarters since.
  • Cowen Inc's Zevra Therapeutics position peaked at $1.76M in Q3 2018.
  • 32 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.